• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0000
    High 0.0000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNUNZ
Nunzia Pharmaceutical Corp
430.0
0.0x
---
United StatesLSDIF
Lucy Scientific Discovery Inc
10.6K
0.0x
---
United StatesONPH
Oncology Pharma Inc
3.9K
0.0x
---
United StatesNXGB
Nxgen Brands Inc
18.3K
---
---
United StatesMDCN
Medican Enterprises Inc
38.9K
0.0x
---
United StatesSIGO
Sunset Island Group Inc
590.0
0.0x
---
As of 2024-11-22

Company Information

Nunzia Pharmaceutical Corporation is a pharmaceutical company. The Company focuses on development and delivery of pharmaceutical and nutraceutical-based therapies for the behavioral symptoms of Autistic Spectrum of Disorders (ASDs) and related conditions, such as Fragile X syndrome, as well as common anxiety-based disorders. The Company has developed NUNZIA, which is a combination of 16 vitamins, minerals and herbs which directly focuses and targets the hippocampus area of the brain, where all anxiety-based disorders originate.

Contact Information

Headquarters
1627 WEST 14TH STREETLONG BEACH, CA, United States 90813
Phone
714-609-9117
Fax
972-386-7864

Executives

Chairman of the Board, Chief Executive Officer
R. Steve Mills
Chief Financial Officer, Vice President
Kingman Hitz
Chief Operating Officer, Senior Vice President, Treasurer, Secretary, Director
Roger Kron
Director
G.David Henry
Director
Mary Pohlmeier

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$430.00
Revenue (TTM)
$0.00
Shares Outstanding
434.5M
Nunzia Pharmaceutical Corp does not pay a dividend.
Beta
-2.47
EPS
$-0.22
Book Value
$0.00
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.